# A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 Tablets

> **NCT07647783** · PHASE1 · RECRUITING · sponsor: **InnovStone Therapeutics Limited** · enrollment: 112 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** SYH2072 Tablets
- **DRUG:** SYH2072 Placebo

## Key facts

- **NCT ID:** NCT07647783
- **Lead sponsor:** InnovStone Therapeutics Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07647783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07647783, "A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 Tablets". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07647783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*